Hepatitis B And Hepatitis C Viral Infections And Associated Factors Among Patients With Diabetes Visiting Gondar Referral Teaching Hospital, Northwest Ethiopia: A Comparative Cross-Sectional Study

References

• Sorrell MF, Belongia EA, Costa J, et al. National Institutes of Health consensus development conference statement: management of hepatitis B. Hepatology. 2009;49(5 Suppl):S4–S12. doi:10.1002/hep.2294619399804
   PubMed Web of Science ®Google Scholar
• Eke AC, Eke UA, Okafor CI, Ezebialu IU, Ogbuagu C. Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting. Virol J. 2011;8(1):12. doi:10.1186/1743-422X-8-1221226907
   PubMed Web of Science ®Google Scholar
• Zignego A, Ferri C, Pileri S, Caini P, Bianchi F. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis. 2007;39(1):2–17. doi:10.1016/j.dld.2006.06.00816884964
   PubMedGoogle Scholar
• Ayele AG, Gebre-Selassie S. Prevalence and risk factors of hepatitis B and hepatitis C virus infections among patients with chronic liver diseases in public hospitals in Addis Ababa, Ethiopia. ISRN Trop Med. 2013;2013:1–7. doi:10.1155/2013/56382125285308
   PubMedGoogle Scholar
• Lavanchy D, Kane M. Global epidemiology of hepatitis B virus infection In: Yun-Fan L, Fabien Z, editors. Hepatitis B Virus in Human Diseases. New York City: Springer; 2016:187–203.
   Google Scholar
• Basnayake S, Easterbrook P. Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature. J Viral Hepat. 2016;23(7):545–559. doi:10.1111/jvh.1251927028545
   PubMed Web of Science ®Google Scholar
• Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Supplement 1):S81–S90. doi:10.2337/dc14-S08124357215
   PubMed Web of Science ®Google Scholar
• Naing C, Mak JW, Ahmed SI, Maung M. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis. World J Gastroenterol. 2012;18(14):1642–1651. doi:10.3748/wjg.v18.i14.164222529694
   PubMed Web of Science ®Google Scholar
• Reilly ML, Schillie SF, Smith E, et al. Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus. J Diabetes Sci Technol. 2012;6(4):858–866. doi:10.1177/19322968120060041722920812
   PubMedGoogle Scholar
• Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign‐born persons living in the United States by country of origin. Hepatology. 2012;56(2):422–433. doi:10.1002/hep.2480422105832
   PubMed Web of Science ®Google Scholar
• Organization WH. Global Report on Diabetes. World Health Organization; 2016.
   Google Scholar
• Schillie S, Xing J, Murphy T, Hu D. Prevalence of hepatitis B virus infection among persons with diagnosed diabetes mellitus in the United States, 1999–2010. J Viral Hepat. 2012;19(9):674–676. doi:10.1111/j.1365-2893.2012.01616.x22863272
   PubMed Web of Science ®Google Scholar
• Lu J, Hou X, Tu H, et al. Chronic hepatitis B virus infection status is more prevalent in patients with type 2 diabetes. J Diabetes Investig. 2017;8(4):619–625. doi:10.1111/jdi.12609
   PubMed Web of Science ®Google Scholar
• Ephraim R, Nsiah P, Osakunor D, Adoba P, Sakyi S, Anto E. Seroprevalence of hepatitis B and C viral infections among type 2 diabetics: a cross-sectional study in the Cape Coast Metropolis. Ann Med Health Sci Res. 2014;4(5):719–722. doi:10.4103/2141-9248.14152925328781
   PubMedGoogle Scholar
• Mekonnen D, Gebre-Selassie S, Fantaw S, Hunegnaw A, Mihret A. Prevalence of hepatitis B virus in patients with diabetes mellitus: a comparative cross sectional study at Woldiya General Hospital, Ethiopia. Pan Afr Med J. 2014;17(1). doi:10.11604/pamj.2014.17.40.2465
   Google Scholar
• Ali S, Abera S, Mihret A, Abebe T. Association of hepatitis C virus infection with type II diabetes in Ethiopia: a hospital-based case-control study. Interdiscip Perspect Infect Dis. 2012;2012:1–7. doi:10.1155/2012/354656
   Google Scholar
• Ndako JA, Echeonwu GO, Shidali NN, et al. Occurrence of hepatitis C virus infection in type 2 diabetic patients attending Plateau state specialist hospital Jos Nigeria. Virol J. 2009;6(1):98. doi:10.1186/1743-422X-6-1919586535
   PubMed Web of Science ®Google Scholar
• Ramana BV, Sreedhar BKV, Chaudhury A. Prevalence of hepatitis C virus infection in type 2 diabetic patients at a tertiary care hospital. Mintage J Pharm Med Sci. 2013;2(4):23–25.
   Google Scholar
• Greca LF, Pinto L, Rados D, Canani L, Gross JL. Clinical features of patients with type 2 diabetes mellitus and hepatitis C infection. Braz J Med Biol Res. 2012;45(3):284–290. doi:10.1590/s0100-879x201200750001322286533
   PubMed Web of Science ®Google Scholar
• Jadoon NA, Shahzad MA, Yaqoob R, Hussain M, Ali N. Seroprevalence of hepatitis C in type 2 diabetes: evidence for a positive association. Virol J. 2010;7(1):304. doi:10.1186/1743-422X-7-30421054842
   PubMed Web of Science ®Google Scholar
• Aboud RS. The relationship between hepatitis C virus infection and diabetes mellitus type 2. J Pharm Chem Biol Sci. 2015;3:73–78.
   Google Scholar
• Khan N, Khan N, Hussain J, Ullah H, Khan H. Frequency of Hepatitis C in type 2 diabetic patients. Gomal J Med Sci. 2014;12(2).
   Google Scholar
• El-Bendary MM, Abdel Aziz MY, El-Arman MM. Hepatitis C virus infection and diabetic microvascular complications “Arabic abstrcts”. J Taibah Univ Med Sci. 2007;1(2):A3.
   Google Scholar
• Madny AG, Adam AA. Seroprevalence of hepatitis C virus among type 2 diabetes mellitus patients in blue nile state, Sudan. Am J Res Commun N. 2014;2:141–147.
   Google Scholar
• Ba-Essa EM, Mobarak EI, Elrahman SA. Frequency and factors associated with hepatitis C virus infection among patients with diabetes, Dammam, KSA. J Egypt Public Health Assoc. 2016;91(2):53–58. doi:10.1097/01.EPX.0000483164.17996.b827455081
   PubMedGoogle Scholar
• Korkmaz H, Kesli R, Pamuk BO, Ipekci SH, Terzi Y, Kebapcilar L. Assessment of evidence for positive association and seroprevalence of hepatitis B and C in diabetic patients in a developing country. J Investig Med. 2015;63(2):251–257. doi:10.1097/JIM.0000000000000126
   Web of Science ®Google Scholar
• Antonelli A, Ferrari SM, Giuggioli D, et al. Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. World J Diabetes. 2014;5(5):586–600. doi:10.4239/wjd.v5.i5.58625317237
   PubMedGoogle Scholar
• Gao T-T, Qin Z-L, Ren H, Zhao P, Qi Z-T. Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner. Virol J. 2015;12(1):12. doi:10.1186/s12985-015-0241-425645159
   PubMed Web of Science ®Google Scholar